Efficacy and safety of ipragliflozin as add‐on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a multi‐centre, randomized, placebo‐controlled, double‐blind study

AIMS: To examine the efficacy and safety of add‐on ipragliflozin in Japanese patients with type 2 diabetes in the early stage of insulin therapy. METHODS: Patients treated with insulin (bolus component <30% of total daily dose) with/without a dipeptidyl peptidase‐4 (DPP‐4) inhibitor were randomiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishihara, Hisamitsu, Yamaguchi, Susumu, Nakao, Ikko, Okitsu, Akira, Asahina, Seitaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484364/
https://www.ncbi.nlm.nih.gov/pubmed/27436788
http://dx.doi.org/10.1111/dom.12745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484364/
https://www.ncbi.nlm.nih.gov/pubmed/27436788
http://dx.doi.org/10.1111/dom.12745

Ejemplares similares